Bridging Chemistry and Biology: EU Court Clarifies Generic Pathways for Synthetic Peptides Referencing Originator Biological Medicines?

On 23 April 2026, the Court of Justice of the European Union (CJEU), in Case C-118/24 EG Labo Laboratoires Eurogenerics SAS, Theramex France SAS v ANSM et al., provided important clarification on the regulatory treatment of chemically synthesised peptides that reference originator biological medicines under Directive 2001/83/EC.... By: Ropes & Gray LLP